ISTH Criteria for Disseminated Intravascular Coagulation (DIC) scale, Padua scale, D-dimer or Fibrinogen: what is the best predictor of COVID-19 pneumonia progression?

M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine)

Source: Virtual Congress 2021 – COVID - 19 biomarkers
Session: COVID - 19 biomarkers
Session type: E-poster
Number: 656

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine). ISTH Criteria for Disseminated Intravascular Coagulation (DIC) scale, Padua scale, D-dimer or Fibrinogen: what is the best predictor of COVID-19 pneumonia progression?. 656

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary Embolism: Incidence, spectrum of CTPA findings, and correlation of D-dimers with embolus location. Is age-adjusted D-dimers cutoff a better screening method?
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021



The value of revised Geneva scoring system and D-dimer evaluation in the patients with suspicion of pulmonary embolism, admitted to the department of lung diseases
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Thrombotic disorders (blood coagulation test and Padua Prediction Score for risk of lung thrombosis)in hospitalized patients with community-acquired pneumonia (CAP)
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018


Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia?
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021


Risk factors for disseminated intravascular coagulation (DIC) in patients with lung cancer
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016


Integration of the level of D-dimer (D-d) with Wells criteria to improve the prediction of pulmonary embolism (PE) before CT angiography of the lung (CTAL)
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Benefit of using an age-adjusted D-dimer cut-off
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

Clinical significance of C reactive protein and MASTORA score in pulmonary embolism
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014


Improvements in risk stratification (RS): Beyond the pulmonary embolism severity index (PESI) score
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016


The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia
Source: Annual Congress 2011 - Early diagnosis in primary care
Year: 2011



Prognostic value of semiquantitative serum Procalcitonine vs APACHE or SOFA scores in patients with descending necrotizing mediastinitis
Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders
Year: 2015

Prognostic scores in pulmonary embolism: PESI, simplified PESI or PREP?
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Prognostic impact and clinical characteristics of Interstitial Pneumonia with Autoimmune features (IPAF) in a multidisciplinary setting
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

Symptoms, signs, suspicion and setting: a PESI score for cancer-associated pulmonary embolism?
Source: Eur Respir J 2017; 49(1): 1602225; DOI: 10.1183/13993003.02225-2016
Year: 2017


Disseminated intravascular coagulation profiles in patients with septic shock on ECMO
Source: International Congress 2016 – Diagnostic and therapeutic challenges in acute respiratory failure
Year: 2016


A combination of the Wells score with multiorgan ultrasound to stratify patients with suspected pulmonary embolism
Source: International Congress 2015 – Chest ultrasonography: an imaging modality with hidden features
Year: 2015



Age-adjusted D-dimers can safely exclude pulmonary embolism: Implications for a UK district general hospital
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Birmingham Community Acquired Pneumonia Severity score (BCAPS) is a better predictor of mortality than CURB65 in hospitalised patients with community acquired pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014